Study with a live BHV 1 marker vaccine: Assessment of the efficacy with a single administration for the primary course in calves with respect to seroconversion;Untersuchungen mit einem IBR-Marker-Lebendimpfstoff: Zum nachweis eines vereinfachten impfschemas (Grundimmunisierung durch Einmalimpfung)

Tierarztliche Umschau

Volumn 59, Issue 10, 2004, Pages 583-586

  Patel, J R ^a   Didlick, S ^a   Brunner, R ^b  

^a Intervet UK Ltd   (United Kingdom)

^b FTA Mikrobiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BOVILIS; HERPES VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CONTROLLED STUDY; DRUG EFFICACY; HERPES; HUMORAL IMMUNITY; INFECTION PREVENTION; NONHUMAN; SEROCONVERSION; VACCINATION; VACCINIA; VIRUS SHEDDING;

ANIMALIA; BOS TAURUS; BOVINAE; HERPESVIRIDAE; VACCINIA VIRUS;

EID: 7044262886     PISSN: 00493864     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gibbs, E. P. J. und M. M. Rweyemamu (1997): Bovine herpesvirus. Part I. Bovine herpesvirus. Vet. Bulletin. 47, 317-343.
2. Jahnecke V. S., C. Weiss, M. Rehagen, A. Brune und W. Traeder (2004): Felduntersuchung über den Einfluss verschiedener Impfregime mit IBR-Marker-Lebendimpfstoffen auf die Immunantwort von 3 Monate alten Kälbern mit oder ohne maternale Antikörper gegen BHV1. Tierärztl. Umschau 59, 225-229.
3. Kahrs, R. F. (1977): Infectious bovine rhinotracheitis. A review and update. J. Am. Vet. Med. Assoc. 171, 1055-1064.
4. Kendrick, J. W., C. J. York and D. G. McKercher (1956): A controller field trial of a vaccine for infectious bovine rhinotracheitis. Proceedings of the U.S. Livestock Sanitary Association 60, 155-158.
5. Makoschey, B. and G. M. Kei (2000): Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheities. Vet. Rec. 147, 189-191.
6. Nettleton, P. F., J. M Sharp, A. J. Herring and J. A. Herring (1984): Infectious bovine rhinotracheitis virus excretion after vaccination, challenge and immunosuppression. 191-209. In: Wittman, G., R . M. Gaskell and H. J. Rziha (Eds.), Latent Herpes Virus Infections in: Vet. Med. Kluwer Academic Publishers, Van Godewijckstraat 30, P.O.Box 17, 3300 AA Dordrecht, The Netherlands.
7. Patel, J. R. and R. W. Shilleto (2003): Ruminant pestivirus detection and serology based on interference. J. Animals and Veterinary Advances 2, 327-337.
8. Patel, J. R. (2004): Characteristics of live bovine herpesvirus-1 vaccines. (Im Druck). The Veterinary Journal.
9. Schwarz, A. I. F., C. J. York, L. W. Zirbel and L. A. Estela (1957): Modification of infectious bovine rhinotracheitis (IBR) virus in tissue culture and development of a vaccine. Proc. Soc. Exper. Biol. Med. 96, 453-458.
10. Straub, O. C. (1972): Der Übergang von dxer passiven zur aktiven Immunität des Kalbes. Dtsch. Tierärztl. Wschr. 79, 613-615.
11. Sträub, O. C. (2001): Advances in BHV1 (IBR) research. Dtsch.Tierärztl. Wschr. 108, 419-422.
12. Sträub, O. C. (2003): Advantages and disadvantages of common vaccination programmes for cattle. Amtstierärztl. Dienst und Lebensmittelkontrolle 10 (1), 63-69.
13. Van Donkersgoed, J., J. V. Van den Hurk, D. McCartn and Harland, R. J. (1991): Comparative serological responses in calves to eight commercial vaccines against infectious bovine rhinotracheitis, parainfluema bovine respiratory syncytia, and bovine viral diarrhoea. Can. Vet. J. 32, 727-733.
14. Yates, W. D. G. (1982): A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. of Comp. Medicines 46, 225-263.